Merck & Company, Inc. News Headlines

MRK 
$57.88
*  
0.46
0.79%
Get MRK Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Eli Lilly/Boehringer's Diabetes Drug Under FDA Review - Analyst Blog
10/23/2014 3:30:00 PM - Zacks.com


Gilead's Hep C Dream Drug Faces Demanding Investors
10/22/2014 3:44:00 PM - Investor's Business Daily


5-Star And Dow Analysts Give 9% Edge To Lowest-Priced High-Yield Stocks
10/22/2014 9:42:00 AM - Seeking Alpha


Gilead Sciences: Pricing, Politics And Profits
10/21/2014 3:23:00 PM - Seeking Alpha


Market Reaction To Johnson & Johnson's Earnings Is Justified
10/21/2014 12:54:38 PM - Trefis


Gilead Sciences: Clear The Dockets And Settle With Merck Already
10/21/2014 9:07:00 AM - Seeking Alpha


Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2014 Update
10/21/2014 4:52:00 AM - Seeking Alpha


Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog
10/20/2014 5:15:00 PM - Zacks.com


Interesting April 2015 Stock Options for MRK
10/20/2014 11:17:28 AM - BNK Invest


Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha


This Drug Could Outsell Medical Marijuana
10/19/2014 11:02:02 AM - Motley Fool


Confused, Bothered And Bewildered
10/18/2014 6:18:00 PM - Seeking Alpha


Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
10/18/2014 1:07:02 PM - Motley Fool


A Harvoni Vs. Olysio Price War Will Be Nonexistent: Consider Buying Gilead Now
10/17/2014 1:54:00 PM - Seeking Alpha


DLN, T, PFE, MRK: Large Inflows Detected at ETF
10/17/2014 9:56:02 AM - BNK Invest


With Strong Corporate Partnerships, Xenon Pharmaceuticals IPO Looks Appealing
10/16/2014 9:49:00 PM - Seeking Alpha


IPO Preview: Xenon Pharmaceuticals
10/16/2014 11:43:00 AM - Seeking Alpha


Dow Movers: MRK, UNH
10/16/2014 10:59:35 AM - BNK Invest


Dogs Of The Dow: 2014 Third Quarter Review
10/15/2014 4:14:00 PM - Seeking Alpha


Gilead's Harvoni Will Dominate J&J's Olysio In HCV: Is Olysio Even Relevant Anymore?
10/15/2014 9:24:00 AM - Seeking Alpha


Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
10/15/2014 7:45:02 AM - Motley Fool


Merck Still Looks Very Expensive
10/14/2014 3:02:00 PM - Seeking Alpha


Can Dividend Stock GlaxoSmithKline plc Bounce Back?
10/14/2014 12:09:05 PM - Motley Fool


How Retirees Made It Through The Last 2 Recessions
10/14/2014 11:41:00 AM - Seeking Alpha


Merck: Be Prepared For A Buying Opportunity From A Dividend Perspective
10/14/2014 8:03:00 AM - Seeking Alpha